Delivery Order 36C26025D0035-36C26025N0380

Award Date 7/1/25
Potential Completion Date 6/30/26
Potential Value $122K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business. The contract, valued at $769,312.00, is for the delivery of radiopharmaceuticals, including Ga-68 Dotatate, iodine I-123, and various therapeutic radioisotopes critical for nuclear medicine procedures such as positron emission tomography (PET) scans,...
This firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $1,714,114.73 contract is for the delivery of radiopharmaceuticals to support nuclear medicine procedures, including positron emission tomography (PET) scans, cardiac imaging, and cancer treatment diagnostics, for VA medical facilities across multiple Veterans Integrated...
This is a firm-fixed-price delivery order contract awarded to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, by the U.S. Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals. The contract has a total ceiling value of $514,985.56 and a completion date of March 4, 2026. Jubilant Radiopharma is a subsidiary of Jubilant Life Sciences Limited and specializes in the manufacturing, distribution, and...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $218,897.52 contract is for the provision of radiopharmaceuticals and nuclear medicine products, including Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical isotopes, to support nuclear medicine procedures at VA medical facilities. The contract has an ultimate completion date of March 31,...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $200,000.00 and a period of performance through March 31, 2030. Jubilant Radiopharma will provide radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA medical...
The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
This federal contract, valued at $439,477.00, was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business. The contract, awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 15, is for the supply of radiopharmaceuticals, including medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, valued at $31,268.14, is for the supply of radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA medical facilities. Jubilant Radiopharma has been awarded multiple Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, with a ceiling value of $88,977.92, is for the delivery of radiopharmaceuticals to support nuclear medicine procedures, PET scans, cardiac imaging, and cancer treatment diagnostics at VA medical facilities. Jubilant Radiopharma is a subsidiary of...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of radiopharmaceuticals. The $740,177.94 contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health Agency (DHA) worth up...
  • 36C26025D0035
    Indefinite Delivery Contract
  • 36C26025D0035-36C26025N0380
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract, valued at $122,387.32, is for the provision of radiopharmaceuticals to the VA's Veterans Integrated Service Network (VISN) 20.

Jubilant Radiopharma is a leading manufacturer and supplier of medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, with a focus on serving the VA's nuclear medicine needs. The contract is not set aside and covers a range of radiopharmaceutical products, including Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical isotopes. These products support various nuclear medicine procedures such as positron emission tomography (PET) scans, cardiac imaging, and cancer treatment diagnostics for VA healthcare facilities across the country.

The contract has an ultimate completion date of June 30, 2026, and is part of Jubilant Radiopharma's broader portfolio of Indefinite Delivery Vehicles (IDVs) with the VA, including Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with potential values ranging from $420,000 to $39.8 million. These IDVs enable the VA to efficiently procure critical radiopharmaceuticals and related services across its nationwide network of medical facilities.

Generated 7/1/25, 8:26 AM